Concepedia

Joachim Kiemle-Kallee

JK

Statistics

Publications

5

Citations

129

H-Index

5

Active since

1988

Affiliations

Schmerzklinik Kiel(Current)

Joachim Kiemle-Kallee is an author at Schmerzklinik Kiel specializing in alveolar macrophage function, macrophage biology, and immunopathology.

Publications per year

1988–2022

5

Publications

5

Alveolar macrophages in idiopathic pulmonary fibrosis display a more monocyte-like immunophenotype and an increased release of free oxygen radicals

Joachim Kiemle-Kallee, Hans Kreipe, HJ Radzun et al. · European Respiratory Journal · 1991 · 47 citations · Full text

Life Sciences, Immunology, Pathobiology +16

Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis.

H. Kreipe, H. J. Radzun, Klaus Heidorn et al. · PubMed · 1990 · 42 citations

Life Sciences, Immunology, Pathology +10

Diminished activity of tartrate resistant acid phosphatase in alveolar macrophages from patients with active sarcoidosis.

Jürgen Barth, Hans Kreipe, Joachim Kiemle-Kallee et al. · Thorax · 1988 · 16 citations · Full text

Medicine, Immunology, Pathology +11

Interim safety and efficacy results from AURELIO-03: A phase 1 dose escalation study of the IL-2/IL-15 receptor βγ superagonist SOT101 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors.

Elena Garralda, Aung Naing, Vladimir Galvao et al. · Journal of Clinical Oncology · 2022 · 13 citations

Medicine, Oncology, Pharmacology +17

Abstract OT1-03-02: MP0274-CP101: A phase 1, first-in-human, single-arm, multi-center, open-label, dose escalation study to assess safety, tolerability, and pharmacokinetics of MP0274 in patients with advanced HER2-positive solid tumors

Richard D. Baird, Aurelius Omlin, Joachim Kiemle-Kallee et al. · Cancer Research · 2018 · 11 citations

Medicine, Oncology, Pharmacology +17

1–5 of 5